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Urolithiasis analysis in a multiethnic 
population at a tertiary hospital in Nairobi, 
Kenya
Francis K. Wathigo* , Alfred Hayombe and Daniel Maina
Abstract 
Background: Urolithiasis is a global problem whose incidence is reported to be on the rise across the world. Previ-
ously, urolithiasis was reported as being rare among the indigenous African population but recent data suggest 
otherwise. This study reviewed the demographic and clinical characteristics of patients with urolithiasis seen at the 
Aga Khan University hospital Nairobi (AKUHN) as well as the chemical composition of the stones and the modalities of 
therapy used.
Methods: This was a retrospective study which utilized patients’ clinical and laboratory records from 2013 to 2014. 
Sixty-seven symptomatic patients with confirmed urolithiasis formed the study. This study aimed to describe the 
clinical characteristics of patients, modalities of treatment as well as the chemical composition of renal stones from 
patients diagnosed and managed for urolithiasis during a duration spanning 17 months. Wet chemistry was utilized 
for analyzing the chemical composition of the urinary calculi. Data on age, sex, symptoms, radiological investigations 
done, location of the calculi, chemical composition of calculi and therapeutic procedures instituted were extracted 
and analyzed.
Results: Ages ranged from 3 to 87 years with a median of 42; males were the majority (79%) and the commonest 
presenting symptoms were flank pain (91%) and dysuria (19%). The majority of the stones were located in the ureters 
(46%) and at the pelvi-ureteric junction (25%). A statistically significant difference in frequency of lodgment at the 
pelvi-ureteric site between males and females was noted. However, the number of female patients in this study was 
small and studies with larger numbers of female participants are required to confirm this observation. All stones con-
tained calcium and oxalate, often as the only constituents (72%). In the remainder of the stones, other constituents 
such bicarbonate, ammonium, phosphorous, magnesium, uric acid and cystine occurred in varying combinations 
with calcium oxalate. Laser lithotripsy was the most performed therapeutic procedure (77.6%).
Conclusions: Males formed the majority of patient with urolithiasis. Overall, most of the calculi were located in the 
ureters except in women where the pelviureteric location was commoner. Stones containing calcium oxalate only 
were predominant across the age groups and in both sexes. Lithotripsy was the commonest mode of management.
© The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Urolithiasis refers to a condition characterized by the 
formation or occurrence of calculi in the urinary tract. 
The incidence and prevalence rates for urolithiasis vary 
across different regions of the world with higher rates 
reported in countries such as Spain and Turkey [1]. A rise 
in the incidence of urolithiasis has also been documented 
in United States of America [2]. Urolithiasis in tropical 
Africa, though less common than in Western world, is 
increasingly being appreciated as a problem of growing 
importance. Studies conducted in Kenya and in the larger 
East Africa region demonstrate arise in the reported 
cases of urolithiasis in the past 30 years [3, 4]. Underdiag-
nosis however remains a major challenge [5]. In addition, 
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most of the local studies do not describe the chemical 
composition of the renal calculi.
Certain factors have been noted to predispose to devel-
opment of urinary calculi. Metabolic conditions such as 
hypercalciuria, hyperoxaluria, hyperuricosuria, cystinu-
ria and hypocitraturia have been identified as important 
risk factors [6, 7]. Age is another risk factor, with a signifi-
cant rise in incidence of urolithiasis noted after the age of 
40 years [1, 8]. Gender is yet another significant risk factor 
with men predisposed to developing urolithiasis compared 
to women [1, 8]. Race has also been proposed to be signifi-
cant with higher rates noted in Caucasians compared to 
African-Americans and Asians [1, 9]. Aberrations in uri-
nary pH, as well as presence of urinary tract infections are 
additional factors that have been implicated in urolithiasis.
Various studies investigating the composition of renal 
stones in African populations revealed calcium oxalate as 
the commonest compound across the various age groups 
[10–12]. The prevalence of calcium oxalate calculi in 
adults has been shown to be comparable between indus-
trialized and non-industrialized countries but purine and 
struvite stones are commoner in the non-industrialized 
countries [13].
In previous studies conducted in Kenya, the com-
monest presenting clinical features in patients with uro-
lithiasis were pain and haematuria while the commonest 
modes of imaging were ultrasonography and plain 
abdominal radiographs [4]. The majority of calculi were 
located in the renal pelvis and ureters with extracor-
poreal shock wave lithotripsy (ECSWL) the commonest 
mode of treatment [3].
Various methods are available for stone analysis and 
they include wet chemical analysis, thermogravimetry, 
scanning electron microscopy, optic polarizing micros-
copy, spectroscopy, infrared spectroscopy, X-ray powder 
diffraction and elementary distribution analysis. Wet 
chemical analysis is still the most widely utilized tech-
nique for calculi analysis in clinical routine laboratories 
in Africa [14]. This method has lower costs of operation 
but is time-consuming and only suitable for relatively 
large stone specimen. In addition, it has the disadvantage 
of only being able to identify the presence of individual 
ions without differentiating specific compounds. [14].
This study aims to describe the clinical characteristics 
of patients, modalities of treatment as well as the chemi-
cal composition of renal stones from patients diagnosed 
and managed for urolithiasis during a duration spanning 
slightly over 1 year, utilizing wet chemical analysis.
Methods
This was a retrospective study conducted at AKUHN, 
a teaching hospital serving a multi-ethnic population, 
in which patients’ clinical and laboratory records were 
reviewed. Clinical and laboratory records for all patients 
with confirmed urolithiasis at AKUHN, during the period 
spanning from January 2013 to May 2014 were included: 
sixty-seven symptomatic patients with confirmed uro-
lithiasis formed the study. Data relating to demographic 
characteristics, clinical features, modalities of diagnosis 
and treatment were extracted from the clinical records. 
Data concerning stone composition was extracted from 
corresponding laboratory records.
The analytical method used to analyze stones at 
AKUHN was wet chemistry. In brief, the stones were pul-
verized into fine powder and mixed with different liquid 
reagents to detect various chemical components through 
observation of effervescence and color changes.
In statistical analysis, continuous variables were 
expressed as means and medians. Categorical data were 
summarized into percentages. Differences in categorical 
variables between groups were assessed using Chi square 
test or Fisher’s exact test as appropriate. P values less or 
equal to 0.05 were interpreted as statistically significant. 
Statistical analysis was performed using SPSS Statistics 
software version 22 (IBM, Armonk, USA).
Results
The ages ranged from 3 to 87  years with a median of 
42 years and a mean of 43.5 years (SD 17). Only 3 patients 
(4.5%) were aged below 18 years. Males were the majority 
comprising 79% of the patients. The commonest clinical 
features were flank pain (91%), dysuria (19%), nausea/
vomiting (15%) and haematuria (15%). The majority 
of the patients (92.5%) had only one site of lodgment 
involved. The ureters and the pelvi-ureteric junction were 
the anatomical sites most commonly affected. The blad-
der and urethra (11.3%) were less commonly involved 
(Table 1).
Among the imaging studies performed, computerized 
tomography of kidney, ureters and bladder (CT KUB) was 
the most commonly used mode of evaluation (Table 1).
With regards to chemical composition, calcium and 
oxalate were present in all the stones. The majority of 
the calculi (71.6%) contained only calcium and oxalate. 
Stones containing only bicarbonate and calcium oxalate 
as a combination constituted 22.4% of all calculi. Calculi 
containing other constituents such as ammonium and 
cystine were uncommon with combined total of less than 
10% (Table 2).
Stones containing only calcium oxalate predominated 
in both genders as well as in both age groups (Table 3).
There was no statistically significant difference in com-
position of calculi by gender or by age (P > 0.05, Table 3).
The ureters were the commonest sites of lodgment in 
both age groups as well as in males (Table 4). There was 
no significant statistical difference noted in the location 
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of calculi between the two age groups (P  >  0.05). How-
ever, in females, the pelviureteric junction was the com-
monest site of lodgment (64.3%) and this was statistically 
different when compared to males (P = 0.01).
The majority of the patients with urolithiasis (77.6%) 
were managed with laser lithotripsy. Among those 
patients who underwent lithotripsy, a minority (13.5%) 
also had Dormia basket extraction done concurrently 
with lithotripsy. Dormia basket extraction (without 
concurrent laser lithotripsy) was carried out in 7.5% 
of the patients while PCNL was undertaken in 9% of 
the patients. In 38.8% of the patients, stenting was also 
undertaken in addition to the other surgical procedures 
required to address the urinary calculi (Table 5). All the 
patients had positive outcomes and were subsequently 
discharged from hospital following treatment.
Discussion
Our study demonstrated that the majority of patients 
with urolithiasis were male and that the commonest pre-
senting feature was flank pain. These findings are consist-
ent with previous studies from various parts of the world 
[1, 3, 4]. It therefore seems advisable that male patients 
presenting with flank pain be properly evaluated for 
urolithiasis, as various studies have alluded to underdi-
agnosis being of major concern [5]. The majority of the 
stones were located in the ureter and pelviureteric junc-
tion. Again, these findings are consistent with a previous 
study by Ngugi et  al. that showed the ureter and renal 
pelvis to be the commonest anatomical sites of involve-
ment [3]. There was no statistically significant difference 
in anatomical location of lodgment between the two age 
groups analyzed. A statistically significant difference in 
frequency of lodgment at the pelviureteric site between 
males and females was noted (P  =  0.01). However, the 
number of female patients was quite low [14]. Studies 
with larger numbers female participants are required to 
confirm this observation.
The major constituents of the stones were calcium 
and oxalate, findings which are in keeping with previ-
ous studies conducted across various parts of the world 
[7, 10, 11]. There was no statistical difference in chemical 
Table 1 Demographic and  clinical characteristics 
of patients
a n = 71 because four patients had calculi located in two different anatomical 
sites
Demographic and clinical characteristics
Characteristic (n = 67)
Age, median (years) 42
Male, n (%) 53 (79.1)
Female, n (%) 14 (20.9)
Presenting clinical features, %
 Flank pain 91
 Dysuria 19
 Nausea/vomiting 15
 Microscopic haematuria 15
 Fever/chills 10.4
Anatomical sites involved in lodgment of calculi, %
 One site 92.5
 Two sites 7.5
Anatomical site of lodgment of calculi, %a
 Ureter 46.5
 Pelvi-ureteric junction 25.4
 Vesicoureteric junction 16.9
 Others 11.3
Imaging modalities, %
 Computerized tomography (CT KUB) 81
 Abdominal/pelvic ultrasonography 15
 Micturating cystourethrogram 4
Table 2 Composition of urinary calculi
a Multiple specimens submitted to the laboratory for a single patient from one 
surgical procedure were processed as one sample
Constituents, n (%) (n = 67)a
Calcium oxalate only 48 (71.6)
Calcium oxalate + bicarbonate 15 (22.4)
Calcium oxalate + ammonium 1 (1.5)
Calcium oxalate + phosphate 1 (1.5)
Calcium oxalate + ammonium + bicarbonate 1 (1.5)
Calcium Oxalate + ammonium + bicarbonate + phosphate 
uric acid + cystine
1 (1.5)
Table 3 Composition of calculi by age and gender
a The patients were divided into two groups based on the median age
Composition Agea Gender
n (%) <42 years (n = 32) ≥42 years (n = 35) P value Male (n = 53) Female (n = 14) P value
Calcium oxalate only 22 (68.8) 26 (74.3) 0.51 40 (75.5) 8 (57.1) 0.74
Calcium oxalate + bicarbonate 9 (28.1) 6 (17.1) 0.23 12 (22.6) 3 (21.4) 0.50
Others 1 (3.1) 3 (8.6) 0.62 1 (1.9) (1) 3 (21.4) 1.00
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composition of the stones when comparing patients by 
age or gender.
This study goes beyond previous local studies by 
including analysis of the chemical composition of the 
renal calculi. Information on the composition of renal 
calculi is important in understanding the pathophysiol-
ogy of urolithiasis. For instance, struvite stones usually 
occur against a background of urinary tract infection 
while uric acid stones tend to form in unduly acidic urine 
[7]. Information on the chemical composition of stones 
may also influence mode of therapy chosen: brushite (cal-
cium hydrogen phosphate dihydrate) and cystine stones 
are harder and therefore more resistance to shock wave 
lithotripsy [15, 16]. Similarly, chemical agents such as 
sodium citrate or potassium citrate may be used to alka-
linize urine as part of medical management in patients 
with uric acid stones [16, 17].
Laser lithotripsy was the commonest modality of treat-
ment which again is consistent with the results of the 
study done by Ngugi et al. [3].
One drawback of this study was the method of stone 
analysis utilized. Wet chemical analysis suffers the hand-
icap of only being able to identify the presence of indi-
vidual ions without differentiating specific compounds 
in different stone types and mixtures. As a result, this 
method will not, for example differentiate between 
calcium oxalate monohydrate and calcium oxalate dihy-
drate stones. Another limitation is the relatively small 
sample size involved in this study.
Conclusions
We analyzed renal calculi from sixty seven patients using 
wet chemistry technique. Male patients were the majority 
with a male to female ratio of 3.8:1. Overall, the majority 
of the calculi were located in the ureters except in women 
where the pelvi-ureteric location was the commonest. A 
statistically significant difference in frequency of lodg-
ment at the pelvi-ureteric site between males and females 
was noted. Stones containing calcium oxalate only were 
predominant across the age groups and in both sexes. 
Larger studies are however recommended to confirm this 
observation due to the small number of female patients 
involved in this study. Lithotripsy was the commonest 
mode of management.
Abbreviations
AKUHN: Aga Khan University Hospital Nairobi; CT KUB: computerized tomog-
raphy of kidney, ureters and bladder; ECSWL: extracorporeal shock wave 
lithotripsy; PCNL: percutaneous nephrolithotomy; SD: standard deviation.
Authors’ contributions
FW reviewed medical records of the patients with urolithiasis and extracted 
data pertaining to clinical presentation, radiological investigations, chemical 
composition of calculi and modalities of treatment. FW also participated in 
data analysis and preparation of the manuscript with a view to publishing, in 
conjunction with the other co-authors. AW performed wet chemical analysis 
of the urinary stones and participated in drafting the manuscript. DM was 
involved in formulation of the initial concept, data analysis and preparation of 
the final manuscript for submission. All authors read and approved the final 
manuscript.
Acknowledgements
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The dataset supporting the conclusions of this article is available in the ‘fig-
share’ repository (https://figshare.com/s/eb06aa3144a11224fa55).
Table 4 Location of calculi by age and gender
a The patients were divided into two age groups based on the median age
b Total n = 71 because four patients had calculi located in two different anatomical sites
Location Agea Gender
n (%) <42 years (n = 33)b ≥42 years (n = 38)b P value Male (n = 57)b Female (n = 14)b P value
Ureter 16 (48.5) 17 (44.7) 0.72 28 (49.1) 5 (35.7) 0.26
Pelvi-ureteric junction 7 (21.2) 11 (28.9) 0.46 9 (15.8) 9 (64.3) 0.01
Vesicoureteric junction 5 (15.2) 7 (18.4) 0.72 12 (21.1) 0 (0) 0.58
Bladder 3 (9.1) 3 (7.9) 0.85 6 (10.5) 0 (0) 0.33
Urethra 2 (6.1) 0 (0) 0.21 2 (3.5) 0 (0) 0.26
Table 5 Modes of treatment for urolithiasis
Modes of treatment for urolithiasis
Frequency of modality used, n (%) (n = 67)
Ureteroscopy/cystoscopy and laser lithotripsy 52 (77.6)
Ureteroscopy/cystoscopy and Dormia basket extraction 5 (7.5)
Percutaneous nephrolithotomy (PCNL) 6 (9)
Cystolithopaxy 1 (1.5)
Open nephrostomy 1 (1.5)
Spontaneous passage of calculi in urine 3 (3)
Patients in whom stenting was also done 26 (38.8)
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